[go: up one dir, main page]

AU2003265787A8 - Methods of use for novel human polypeptides encoded by polynucleotides - Google Patents

Methods of use for novel human polypeptides encoded by polynucleotides

Info

Publication number
AU2003265787A8
AU2003265787A8 AU2003265787A AU2003265787A AU2003265787A8 AU 2003265787 A8 AU2003265787 A8 AU 2003265787A8 AU 2003265787 A AU2003265787 A AU 2003265787A AU 2003265787 A AU2003265787 A AU 2003265787A AU 2003265787 A8 AU2003265787 A8 AU 2003265787A8
Authority
AU
Australia
Prior art keywords
polynucleotides
methods
polypeptides encoded
novel human
human polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003265787A
Other versions
AU2003265787A1 (en
Inventor
Srinivas Kothakota
Kevin Hestir
Ge Wu
Yan Wang
Min Mei Huang
Pierre Alvaro Beaurang
Lewis T Williams
Hongbing Zhang
Keting Chu
Kristen Pierce
Robert Forgan Halenbeck
Ernestine Lee
Thomas Linnemann
Dirk Behrens
Lin Haishan
Justin G P Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Five Prime Therapeutics Inc
Original Assignee
Five Prime Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Five Prime Therapeutics Inc filed Critical Five Prime Therapeutics Inc
Publication of AU2003265787A8 publication Critical patent/AU2003265787A8/en
Publication of AU2003265787A1 publication Critical patent/AU2003265787A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003265787A 2002-08-29 2003-08-28 Methods of use for novel human polypeptides encoded by polynucleotides Abandoned AU2003265787A1 (en)

Applications Claiming Priority (69)

Application Number Priority Date Filing Date Title
US40665302P 2002-08-29 2002-08-29
US40657902P 2002-08-29 2002-08-29
US40658502P 2002-08-29 2002-08-29
US40660802P 2002-08-29 2002-08-29
US40664202P 2002-08-29 2002-08-29
US40664602P 2002-08-29 2002-08-29
US40658802P 2002-08-29 2002-08-29
US60/406,646 2002-08-29
US60/406,653 2002-08-29
US60/406,642 2002-08-29
US60/406,579 2002-08-29
US60/406,588 2002-08-29
US60/406,585 2002-08-29
US60/406,608 2002-08-29
US41110102P 2002-09-17 2002-09-17
US41095802P 2002-09-17 2002-09-17
US41103502P 2002-09-17 2002-09-17
US41094802P 2002-09-17 2002-09-17
US41104802P 2002-09-17 2002-09-17
US41107302P 2002-09-17 2002-09-17
US41104502P 2002-09-17 2002-09-17
US41096102P 2002-09-17 2002-09-17
US41094902P 2002-09-17 2002-09-17
US41094702P 2002-09-17 2002-09-17
US41095902P 2002-09-17 2002-09-17
US41105502P 2002-09-17 2002-09-17
US41104102P 2002-09-17 2002-09-17
US41102302P 2002-09-17 2002-09-17
US60/411,073 2002-09-17
US60/410,961 2002-09-17
US60/411,055 2002-09-17
US60/410,959 2002-09-17
US60/410,948 2002-09-17
US60/411,035 2002-09-17
US60/410,949 2002-09-17
US60/410,958 2002-09-17
US60/411,048 2002-09-17
US60/410,947 2002-09-17
US60/411,101 2002-09-17
US60/411,041 2002-09-17
US60/411,045 2002-09-17
US60/411,023 2002-09-17
US46371603P 2003-04-18 2003-04-18
US46370803P 2003-04-18 2003-04-18
US60/463,716 2003-04-18
US60/463,708 2003-04-18
US46719903P 2003-05-02 2003-05-02
US46720103P 2003-05-02 2003-05-02
US60/467,201 2003-05-02
US60/467,199 2003-05-02
US47133603P 2003-05-19 2003-05-19
US60/471,336 2003-05-19
US47243003P 2003-05-22 2003-05-22
US60/472,430 2003-05-22
US47664103P 2003-06-09 2003-06-09
US60/476,641 2003-06-09
US48521803P 2003-07-08 2003-07-08
US48522403P 2003-07-08 2003-07-08
US60/485,218 2003-07-08
US60/485,224 2003-07-08
US48644603P 2003-07-14 2003-07-14
US60/486,446 2003-07-14
US48689103P 2003-07-15 2003-07-15
US60/486,891 2003-07-15
US49357703P 2003-08-08 2003-08-08
US49334103P 2003-08-08 2003-08-08
US60/493,577 2003-08-08
US60/493,341 2003-08-08
PCT/US2003/026864 WO2004020591A2 (en) 2002-08-29 2003-08-28 Methods of use for novel human polypeptides encoded by polynucleotides

Publications (2)

Publication Number Publication Date
AU2003265787A8 true AU2003265787A8 (en) 2004-03-19
AU2003265787A1 AU2003265787A1 (en) 2004-03-19

Family

ID=34317894

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003265787A Abandoned AU2003265787A1 (en) 2002-08-29 2003-08-28 Methods of use for novel human polypeptides encoded by polynucleotides

Country Status (2)

Country Link
AU (1) AU2003265787A1 (en)
WO (1) WO2004020591A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
GB0426146D0 (en) 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
ES2690786T3 (en) 2012-02-15 2018-11-22 Novo Nordisk A/S Antibodies that bind peptidoglycan recognition protein 1
RS56593B1 (en) 2012-02-15 2018-02-28 Novo Nordisk As Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (trem-1)
US9550830B2 (en) 2012-02-15 2017-01-24 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
AU2015289054B2 (en) 2014-07-17 2021-04-08 Novo Nordisk A/S Site directed mutagenesis of trem-1 antibodies for decreasing viscosity
JP7699927B2 (en) 2018-04-02 2025-06-30 ブリストル－マイヤーズ スクイブ カンパニー Anti-TREM-1 Antibodies and Uses Thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555654B1 (en) * 1997-04-15 2003-04-29 The Wellcome Trust Limited As Trustee For The Wellcome Trust LDL-receptor
US20010025098A1 (en) * 1998-03-13 2001-09-27 Incyte Pharmaceuticals, Inc. Human membrane-spanning proteins

Also Published As

Publication number Publication date
WO2004020591A3 (en) 2005-03-24
WO2004020591A2 (en) 2004-03-11
AU2003265787A1 (en) 2004-03-19

Similar Documents

Publication Publication Date Title
AU2003294217A8 (en) Human polypeptides encoded by polynucleotides and methods of their use
GB0307918D0 (en) Therapeutic use
EP1551426A4 (en) Methods of administering fgf18
IL207422A0 (en) Improved recombinant human interferon-beta-ib polypeptides
AU2003279841A8 (en) Uses of human zven antagonists
GB0219660D0 (en) Therapeutic use
AU2003265787A8 (en) Methods of use for novel human polypeptides encoded by polynucleotides
AU2003298606A8 (en) Human polypeptides encoded by polynucleotides and methods of their use
AU2003294236A8 (en) Methods of use for novel human polypeptides encoded by polynucleotides
AU2003236542A8 (en) Novel polynucleotides encoding lamprey gnrh-iii
GB0210741D0 (en) Methods of therapy
PL375356A1 (en) Claudin polypeptides, polynucleotides, and methods of making and use thereof
GB0217493D0 (en) Novel methods of treatment
AU2003284967A8 (en) Novel mouse polypeptides encoded by polynucleotides and methods of their use
AU2003286636A8 (en) Novel human polypeptides encoded by polynucleotides
AU2003274935A8 (en) Novel human polypeptides encoded by polynucleotides
GB0208392D0 (en) Therapeutic compounds
AU2003231937A8 (en) Therapeutic methods
AU2003274934A8 (en) Novel mouse polypeptides encode by polynucleotides and methods of their use
EP1489178A4 (en) Polypeptides binding to human syntaxin 1a
GB0218316D0 (en) Improvements relating to therapy
TW571748U (en) Multifunctional therapeutic oxygen generator
GB0207139D0 (en) Novel therapeutic treatment
GB0207138D0 (en) Novel therapeutic treatment
GB0226865D0 (en) Therapeutic use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase